A Phase 2 Trial to Test Safety and Efficacy of ST-100, a Unique Collagen Mimetic Peptide Ophthalmic Solution for Dry Eye Disease.

Baratta RO, Schlumpf E, Del Buono BJ, DeLorey S, Ousler G, Calkins DJ

Open source

DOI
10.1016/j.xops.2023.100451
Published
2024 May-Jun
Container
Ophthalmology science
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.xops.2023.100451,
  title = {A Phase 2 Trial to Test Safety and Efficacy of ST-100, a Unique Collagen Mimetic Peptide Ophthalmic Solution for Dry Eye Disease.},
  author = {Baratta RO and Schlumpf E and Del Buono BJ and DeLorey S and Ousler G and Calkins DJ},
  year = {2024},
  journal = {Ophthalmology science},
  doi = {10.1016/j.xops.2023.100451},
  url = {https://doi.org/10.1016/j.xops.2023.100451}
}

RIS

TY  - JOUR
TI  - A Phase 2 Trial to Test Safety and Efficacy of ST-100, a Unique Collagen Mimetic Peptide Ophthalmic Solution for Dry Eye Disease.
AU  - Baratta RO
AU  - Schlumpf E
AU  - Del Buono BJ
AU  - DeLorey S
AU  - Ousler G
AU  - Calkins DJ
PY  - 2024
JO  - Ophthalmology science
DO  - 10.1016/j.xops.2023.100451
UR  - https://doi.org/10.1016/j.xops.2023.100451
ER  - 

APA

RO, B., E, S., BJ, D. B., S, D., G, O., & DJ, C. (2024). A Phase 2 Trial to Test Safety and Efficacy of ST-100, a Unique Collagen Mimetic Peptide Ophthalmic Solution for Dry Eye Disease.. Ophthalmology science. https://doi.org/10.1016/j.xops.2023.100451

Source records